151 related articles for article (PubMed ID: 11801582)
1. Ten years' experience with liposomal amphotericin B in transplant recipients at Huddinge University Hospital.
Ringdén O
J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():51-5. PubMed ID: 11801582
[TBL] [Abstract][Full Text] [Related]
2. Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children.
Tollemar J; Klingspor L; Ringdén O
Clin Microbiol Infect; 2001; 7 Suppl 2():68-79. PubMed ID: 11525221
[TBL] [Abstract][Full Text] [Related]
3. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.
Kelsey SM; Goldman JM; McCann S; Newland AC; Scarffe JH; Oppenheim BA; Mufti GJ
Bone Marrow Transplant; 1999 Jan; 23(2):163-8. PubMed ID: 10197802
[TBL] [Abstract][Full Text] [Related]
4. A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients.
Tollemar J; Andersson S; Ringdén O; Tydén G
Mycoses; 1992; 35(9-10):215-20. PubMed ID: 1291871
[TBL] [Abstract][Full Text] [Related]
5. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.
Tollemar J; Ringdén O; Andersson S; Sundberg B; Ljungman P; Tydén G
Bone Marrow Transplant; 1993 Dec; 12(6):577-82. PubMed ID: 8136741
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.
Ringdén O; Andström EE; Remberger M; Dahllöf G; Svahn BM; Tollemar J
Pediatr Transplant; 1997 Nov; 1(2):124-9. PubMed ID: 10084772
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.
Wiley JM; Seibel NL; Walsh TJ
Pediatr Infect Dis J; 2005 Feb; 24(2):167-74. PubMed ID: 15702047
[TBL] [Abstract][Full Text] [Related]
8. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
Shah T; Lai WK; Gow P; Leeming J; Mutimer D
Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401
[TBL] [Abstract][Full Text] [Related]
9. Liposomal amphotericin B for the treatment of severe fungal infection.
Michaud D
Dynamics; 2001; 12(1):17-21. PubMed ID: 11982230
[TBL] [Abstract][Full Text] [Related]
10. Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B.
Chen SC;
J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():57-61. PubMed ID: 11801583
[TBL] [Abstract][Full Text] [Related]
11. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation.
Krüger W; Stockschläder M; Rüssmann B; Berger C; Hoffknecht M; Sobottka I; Kohlschütter B; Kroschke G; Kröger N; Horstmann M
Br J Haematol; 1995 Nov; 91(3):684-90. PubMed ID: 8555076
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients.
Andström EE; Ringdén O; Remberger M; Svahn BM; Tollemar J
Mycoses; 1996; 39(5-6):185-93. PubMed ID: 8909028
[TBL] [Abstract][Full Text] [Related]
13. Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.
Coukell AJ; Brogden RN
Drugs; 1998 Apr; 55(4):585-612. PubMed ID: 9561346
[TBL] [Abstract][Full Text] [Related]
14. Use of liposomal amphotericin B in bone marrow transplant.
Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H
J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256
[TBL] [Abstract][Full Text] [Related]
15. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study.
Tollemar J; Höckerstedt K; Ericzon BG; Jalanko H; Ringdén O
Transplantation; 1995 Jan; 59(1):45-50. PubMed ID: 7839427
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
Wingard JR
Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
[TBL] [Abstract][Full Text] [Related]
17. Liposomal amphotericin B in critically ill paediatric patients.
Sideri G; Falagas ME; Grigoriou M; Vouloumanou EK; Papadatos JH; Lebessi E; Kafetzis DA
J Clin Pharm Ther; 2012 Jun; 37(3):291-5. PubMed ID: 21777406
[TBL] [Abstract][Full Text] [Related]
18. AmBisome in the treatment of fungal infections: the UK experience.
Chopra R
J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():43-7. PubMed ID: 11801580
[TBL] [Abstract][Full Text] [Related]
19. Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients.
Chopra R; Blair S; Strang J; Cervi P; Patterson KG; Goldstone AH
J Antimicrob Chemother; 1991 Oct; 28 Suppl B():93-104. PubMed ID: 1778896
[TBL] [Abstract][Full Text] [Related]
20. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]